Gene · 6921
NIH grants1,232
NIH grants whose papers are about the gene, through NIH's grant-paper links.
361 to 380 of 1,232
Download this page as JSON| Grant | Title | ELOC papers | Newest fiscal year |
|---|---|---|---|
| R01CA208267 | Targeting the menin-MLL1 complex for new therapeutics | 1 | 2022 |
| R01CA214703 | DKK2 regulates NK activation and tumor immunity | 1 | 2022 |
| R01CA221969 | Improving the efficacy of mTOR inhibition | 1 | 2022 |
| R01CA227001 | A SIGNALING PATHWAY SPECIFIC FOR ALKYLATION DAMAGE | 1 | 2022 |
| R01ES029212 | Placental Functional Networks Linking Developmental Pesticide Exposure and Offspring Neurodevelopment | 1 | 2022 |
| R01GM108583 | Investigation of DNA Modifying Enzymes by Computational Simulations: Development and Applications | 1 | 2022 |
| R01GM109463 | Regulation of cell migration and signaling by phosphotyrosine and ubiquitin | 1 | 2022 |
| R01GM129090 | Defining Pathway-Specific Kinase Signaling Modules with Proteomics | 1 | 2022 |
| R01GM130885 | Interface-resolution domain-domain interactome map of the yeast complexome | 1 | 2022 |
| R01GM131101 | Phosphoinositide-Binding Proteins as Regulators of Ubiquitination and Wnt Signaling | 1 | 2022 |
| R01HL101200 | Systems Biology of Angiogenesis in Peripheral Arterial Disease | 1 | 2022 |
| R01HL127240 | Regulation of Chromatin Signaling in Heart Failure by the BRD4 Bromodomain Protein. | 1 | 2022 |
| R01HL142777 | DCAF7/HDAC4/TFEB axis in acute lung injury | 1 | 2022 |
| R03HL150412 | Computational Prioritization of Coding and Non-Coding Variants in Congenital Heart Disease | 1 | 2022 |
| R21AI156907 | Multiplex discovery of synthetic host-protein combinations that inhibit HIV | 1 | 2022 |
| R35CA210085 | Studies on oncoprotein-induced feedback: Basic and therapeutic implications | 1 | 2022 |
| T32CA174648 | Training in Translational Research of Lung, Head and Neck Cancer | 1 | 2022 |
| T32GM007388 | Predoctoral Training in Genetics and Molecular Biology | 1 | 2022 |
| T32GM008061 | Cellular and Molecular Basis of Disease Training Program | 1 | 2022 |
| T32GM008570 | Molecular and Cellular Biophysics Training Grant | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6921/grants?page=19